Guangxi LiuYao Group Co Ltd
SSE:603368
Relative Value
The Relative Value of one Guangxi LiuYao Group Co Ltd stock under the Base Case scenario is 55.74 CNY. Compared to the current market price of 22.79 CNY, Guangxi LiuYao Group Co Ltd is Undervalued by 59%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Guangxi LiuYao Group Co Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
CN |
G
|
Guangxi LiuYao Group Co Ltd
SSE:603368
|
9.1B CNY | 0.4 | 11.4 | 12 | 12 | |
US |
Mckesson Corp
NYSE:MCK
|
68.5B USD | 0.2 | 22.9 | 15.9 | 18.5 | ||
US |
Cencora Inc
NYSE:COR
|
44.4B USD | 0.2 | 23.8 | 12.2 | 17.2 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | 20.9 | 11.3 | 15.2 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
24.1B USD | 0.1 | 37.8 | 8.4 | 11.3 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
US |
Henry Schein Inc
NASDAQ:HSIC
|
8.8B USD | 0.7 | 21.3 | 11.3 | 15.2 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
57.6B CNY | 1.4 | 21.3 | 15.5 | 15.5 | ||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
61.2B HKD | 0.1 | 6.3 | 1.5 | 1.8 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.2B EUR | 3.2 | 46.6 | 15 | 29.6 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51B CNY | 0.2 | 13.5 | 8 | 8 |